(Q34109255)

English

Younger age, higher body mass index and lower adiponectin concentration predict higher serum thromboxane B2 level in aspirin-treated patients with type 2 diabetes: an observational study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

31 July 2017

Younger age, higher body mass index and lower adiponectin concentration predict higher serum thromboxane B2 level in aspirin-treated patients with type 2 diabetes: an observational study (English)

1 reference

Europe PubMed Central

31 July 2017

1 reference

based on heuristic

inferred from title

type 2 diabetes

1 reference

based on heuristic

inferred from title

Agnieszka Kaplon-Cieslicka

1

object named as

Agnieszka Kaplon-Cieslicka

1 reference

Europe PubMed Central

31 July 2017

Krzysztof Jerzy Filipiak

9

object named as

Krzysztof J Filipiak

1 reference

Europe PubMed Central

31 July 2017

Grzegorz Opolski

8

object named as

Grzegorz Opolski

1 reference

Europe PubMed Central

31 July 2017

Agnieszka Kondracka

5

object named as

Agnieszka Kondracka

1 reference

Europe PubMed Central

31 July 2017

2

object named as

Marek Postula

1 reference

Europe PubMed Central

31 July 2017

4

object named as

Michal Peller

1 reference

Europe PubMed Central

31 July 2017

author name string

Marek Rosiak

3

1 reference

Europe PubMed Central

31 July 2017

Agnieszka Serafin

6

1 reference

Europe PubMed Central

31 July 2017

Ewa Trzepla

7

1 reference

Europe PubMed Central

31 July 2017

language of work or name

0 references

publication date

15 August 2014

1 reference

Europe PubMed Central

31 July 2017

Cardiovascular Diabetology

1 reference

Europe PubMed Central

31 July 2017

13

1 reference

Europe PubMed Central

31 July 2017

112

1 reference

Europe PubMed Central

31 July 2017

copyright license

Creative Commons Attribution 4.0 International

15 August 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

https://scigraph.springernature.com/pub.10.1186/s12933-014-0112-0

0 references

Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149275

28 July 2018

Role of adiponectin in metabolic and cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149275

28 July 2018

Non-HDL cholesterol is an independent risk factor for aspirin resistance in obese patients with type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149275

28 July 2018

Differences in thrombus structure and kinetics in patients with type 2 diabetes mellitus after non ST elevation acute coronary syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149275

28 July 2018

Prevalence of high on-treatment platelet reactivity in diabetic patients treated with aspirin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149275

28 July 2018

Standards of medical care in diabetes--2014

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149275

28 July 2018

Aspirin resistance in patients with type II diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149275

28 July 2018

A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149275

28 July 2018

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149275

28 July 2018

The effect of doubling the dose of acetylsalicylic acid (ASA) on platelet function parameters in patients with type 2 diabetes and platelet hyperreactivity during treatment with 75 mg of ASA: a subanalysis of the AVOCADO study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149275

28 July 2018

Drug Resistance and Pseudoresistance: An Unintended Consequence of Enteric Coating Aspirin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149275

28 July 2018

High glucose inhibits the aspirin-induced activation of the nitric oxide/cGMP/cGMP-dependent protein kinase pathway and does not affect the aspirin-induced inhibition of thromboxane synthesis in human platelets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149275

28 July 2018

Spontaneous platelet aggregation evaluated by laser light scatter in patients with type 2 diabetes: effects of short-term improved glycemic control and adiponectin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149275

28 July 2018

Globular adiponectin counteracts VCAM-1-mediated monocyte adhesion via AdipoR1/NF-κB/COX-2 signaling in human aortic endothelial cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149275

28 July 2018

Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149275

28 July 2018

Clinical determinants of aspirin resistance in diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149275

28 July 2018

Factors contributing to increased platelet reactivity in people with diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149275

28 July 2018

Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Wo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149275

28 July 2018

Adipokines and insulin resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149275

28 July 2018

Aspirin and clopidogrel response variability: review of the published literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149275

28 July 2018

Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149275

28 July 2018

No case of COX-1-related aspirin resistance found in 289 patients with symptoms of stable CHD remitted for coronary angiography

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149275

28 July 2018

High levels of low-density lipoprotein cholesterol and triglycerides and suboptimal glycemic control predict diminished ex vivo aspirin responsiveness in patients with Type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149275

28 July 2018

Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149275

28 July 2018

Increased basal platelet activity, plasma adiponectin levels, and diabetes mellitus are associated with poor platelet responsiveness to in vitro effect of aspirin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149275

28 July 2018

Aspirin resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149275

28 July 2018

Comparison of aspirin resistance in type 1 versus type 2 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149275

28 July 2018

Adiponectin acts as an endogenous antithrombotic factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149275

28 July 2018

Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149275

28 July 2018

Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)-its relation to metabolic control

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149275

28 July 2018

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149275

28 July 2018

The kinetics of plasma aspirin esterase in relation to old age and frailty

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149275

28 July 2018

Aspirin resistance is associated with glycemic control, the dose of aspirin, and obesity in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0112-0

21 January 2018

Platelet reactivity in type 2 diabetes mellitus: a comparative analysis with survivors of myocardial infarction and the role of glycaemic control.

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0112-0

21 January 2018

The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0112-0

21 January 2018

Reduced platelet response to aspirin in patients with coronary artery disease and type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0112-0

21 January 2018

Interindividual variability in the efficacy of oral antiplatelet drugs: definitions, mechanisms and clinical importance

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0112-0

21 January 2018

Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0112-0

21 January 2018

Regulation of protein kinase C by short term hyperglycaemia in human platelets in vivo and in vitro.

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0112-0

21 January 2018

Aspirin resistance associated with HbA1c and obesity in diabetic patients

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0112-0

21 January 2018

COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment.

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0112-0

21 January 2018

Inhibition of platelet GPIIb-IIIa and P-selectin expression by aspirin is impaired by stress hyperglycemia

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0112-0

21 January 2018

Insulin resistance as a determinant of platelet activation in obese women.

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0112-0

21 January 2018

Predictors of high platelet reactivity during aspirin treatment in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0112-0

21 January 2018

Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0112-0

21 January 2018

The effect of metformin on mean platelet volume in dıabetıc patients

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0112-0

21 January 2018

Plasma esterases and inflammation in ageing and frailty

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0112-0

21 January 2018

Increased blood plasma hydrolysis of acetylsalicylic acid in type 2 diabetic patients: a role of plasma esterases

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0112-0

21 January 2018

Antiplatelet effect of once- or twice-daily aspirin dosage in stable coronary artery disease patients with diabetes

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0112-0

21 January 2018

Platelet hyperaggregability in high-fat fed rats: a role for intraplatelet reactive-oxygen species production.

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0112-0

21 January 2018

Platelet activation in obese women: role of inflammation and oxidant stress

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0112-0

21 January 2018

The role of weight and enteric coating on aspirin response in cardiovascular patients

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0112-0

21 January 2018

Total and high molecular weight adiponectin and ethnic-specific differences in adiposity and insulin resistance: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0112-0

21 January 2018

Adiponectin diminishes platelet aggregation and sCD40L release. Potential role in the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0112-0

21 January 2018

Adiponectin stimulates production of nitric oxide in vascular endothelial cells.

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0112-0

21 January 2018

Thromboxane Production in Morbidly Obese Subjects

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0112-0

21 January 2018

Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications

1 reference

https://api.crossref.org/works/10.1186%2FS12933-014-0112-0

21 January 2018

Response variability to aspirin as assessed by the platelet function analyzer (PFA)-100

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4149275

28 October 2018

Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25123549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiplatelet therapy in patients with diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/25123549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adiponectin, ghrelin, and leptin differentially influence human platelet and human vascular endothelial cell functions: implication in obesity-associated cardiovascular diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/25123549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic determinants of platelet reactivity during acetylsalicylic acid therapy in diabetic patients: evaluation of 27 polymorphisms within candidate genes

1 reference

https://pubmed.ncbi.nlm.nih.gov/25123549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/25123549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced antiplatelet effect of aspirin during 24 hours in patients with coronary artery disease and type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/25123549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biological efficacy of twice daily aspirin in type 2 diabetic patients with coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25123549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of aspirin dose and glycemic control on platelet inhibition in patients with type 2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/25123549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adiponectin inhibits hyperlipidemia-induced platelet aggregation via attenuating oxidative/nitrative stress

1 reference

https://pubmed.ncbi.nlm.nih.gov/25123549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platelet activation is associated with hypoadiponectinemia and carotid atherosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25123549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aspirin esterases in North-West Indians: the influence of age and nutrition

1 reference

https://pubmed.ncbi.nlm.nih.gov/25123549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

24-hour time-dependent aspirin efficacy in patients with stable coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25123549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/S12933-014-0112-0

1 reference

Europe PubMed Central

31 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34109255&oldid=1860864848"